

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.03006479 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.25395758 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.25395758 |
| 4 | B cell receptor signaling pathway (GO:0050853) | 5.46993091 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.43993872 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.30090932 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 5.27195258 |
| 8 | regulation of B cell differentiation (GO:0045577) | 5.25874128 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.32564183 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.20972875 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.13591054 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.10566680 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.05303017 |
| 14 | negative regulation of phagocytosis (GO:0050765) | 3.97993517 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.93860198 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 3.87605760 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84394939 |
| 18 | cellular response to zinc ion (GO:0071294) | 3.71069134 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 3.66262321 |
| 20 | response to peptidoglycan (GO:0032494) | 3.58338485 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53246302 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.53246302 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.50160233 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.50160233 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.50160233 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.50160233 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.50160233 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.50160233 |
| 29 | N-acetylneuraminate metabolic process (GO:0006054) | 3.50084789 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.47425515 |
| 31 | positive regulation of interferon-alpha production (GO:0032727) | 3.43937813 |
| 32 | defense response to protozoan (GO:0042832) | 3.43233827 |
| 33 | negative regulation of B cell proliferation (GO:0030889) | 3.40543775 |
| 34 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.30738610 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.30529887 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 3.28320938 |
| 37 | amino sugar catabolic process (GO:0046348) | 3.27042548 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21060213 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.19823841 |
| 40 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.18506643 |
| 41 | leukocyte aggregation (GO:0070486) | 3.18181912 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.18083571 |
| 43 | mature B cell differentiation (GO:0002335) | 3.14509362 |
| 44 | response to protozoan (GO:0001562) | 3.12090053 |
| 45 | regulation of mast cell activation (GO:0033003) | 3.11870519 |
| 46 | oligosaccharide catabolic process (GO:0009313) | 3.11621244 |
| 47 | B cell mediated immunity (GO:0019724) | 3.10381534 |
| 48 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.08013335 |
| 49 | respiratory burst (GO:0045730) | 3.07562104 |
| 50 | regulation of B cell apoptotic process (GO:0002902) | 3.07270936 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.06819007 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 3.05761641 |
| 53 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02967083 |
| 54 | positive regulation of mast cell activation (GO:0033005) | 3.02817038 |
| 55 | glycosphingolipid catabolic process (GO:0046479) | 3.02758070 |
| 56 | T cell homeostasis (GO:0043029) | 3.00124552 |
| 57 | lymphocyte homeostasis (GO:0002260) | 2.99809498 |
| 58 | response to interleukin-15 (GO:0070672) | 2.99418661 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 2.99399508 |
| 60 | regulation of B cell proliferation (GO:0030888) | 2.98186057 |
| 61 | positive regulation of defense response to virus by host (GO:0002230) | 2.96316272 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 2.96132575 |
| 63 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.94701436 |
| 64 | cellular extravasation (GO:0045123) | 2.94332927 |
| 65 | neutrophil activation (GO:0042119) | 2.93841708 |
| 66 | lysosome organization (GO:0007040) | 2.93526886 |
| 67 | lytic vacuole organization (GO:0080171) | 2.93526886 |
| 68 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93090669 |
| 69 | negative thymic T cell selection (GO:0045060) | 2.91896644 |
| 70 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.90501089 |
| 71 | germinal center formation (GO:0002467) | 2.87897333 |
| 72 | regulation of mononuclear cell migration (GO:0071675) | 2.85922556 |
| 73 | B cell proliferation (GO:0042100) | 2.85799726 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.84769479 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 2.84769479 |
| 76 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.84253957 |
| 77 | B cell homeostasis (GO:0001782) | 2.84085447 |
| 78 | natural killer cell mediated immunity (GO:0002228) | 2.84048359 |
| 79 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.84048359 |
| 80 | mature B cell differentiation involved in immune response (GO:0002313) | 2.83571252 |
| 81 | natural killer cell differentiation (GO:0001779) | 2.83265716 |
| 82 | detection of other organism (GO:0098543) | 2.81634866 |
| 83 | response to type I interferon (GO:0034340) | 2.81131642 |
| 84 | regulation of response to interferon-gamma (GO:0060330) | 2.80715707 |
| 85 | tryptophan catabolic process (GO:0006569) | 2.80356418 |
| 86 | indole-containing compound catabolic process (GO:0042436) | 2.80356418 |
| 87 | indolalkylamine catabolic process (GO:0046218) | 2.80356418 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80140642 |
| 89 | negative regulation of interleukin-6 production (GO:0032715) | 2.78255087 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.77968513 |
| 91 | type I interferon signaling pathway (GO:0060337) | 2.77369825 |
| 92 | cellular response to type I interferon (GO:0071357) | 2.77369825 |
| 93 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.77222913 |
| 94 | negative regulation of mast cell activation (GO:0033004) | 2.76963100 |
| 95 | cellular response to exogenous dsRNA (GO:0071360) | 2.76950214 |
| 96 | detection of bacterium (GO:0016045) | 2.76380637 |
| 97 | thymic T cell selection (GO:0045061) | 2.75317699 |
| 98 | tolerance induction (GO:0002507) | 2.74835764 |
| 99 | leukocyte homeostasis (GO:0001776) | 2.74594938 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 2.74343042 |
| 101 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.74331195 |
| 102 | mannose metabolic process (GO:0006013) | 2.73500004 |
| 103 | reactive oxygen species biosynthetic process (GO:1903409) | 2.72653020 |
| 104 | positive regulation of B cell activation (GO:0050871) | 2.72257920 |
| 105 | glycolipid catabolic process (GO:0019377) | 2.71966936 |
| 106 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71860379 |
| 107 | regulation of antigen processing and presentation (GO:0002577) | 2.71762571 |
| 108 | leukocyte mediated cytotoxicity (GO:0001909) | 2.70709354 |
| 109 | negative T cell selection (GO:0043383) | 2.70539521 |
| 110 | cellular response to interferon-beta (GO:0035458) | 2.70163960 |
| 111 | regulation of B cell activation (GO:0050864) | 2.69989189 |
| 112 | superoxide anion generation (GO:0042554) | 2.68883225 |
| 113 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.68773924 |
| 114 | negative regulation of granulocyte differentiation (GO:0030853) | 2.68022295 |
| 115 | T-helper 1 type immune response (GO:0042088) | 2.66629731 |
| 116 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66338760 |
| 117 | positive regulation of type 2 immune response (GO:0002830) | 2.66289106 |
| 118 | granulocyte activation (GO:0036230) | 2.66101593 |
| 119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.64985752 |
| 120 | regulation of interleukin-12 production (GO:0032655) | 2.64301132 |
| 121 | regulation of cholesterol storage (GO:0010885) | 2.63928923 |
| 122 | hepatocyte apoptotic process (GO:0097284) | 2.63499219 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.63290533 |
| 124 | detection of external biotic stimulus (GO:0098581) | 2.61934647 |
| 125 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61848640 |
| 126 | negative regulation of innate immune response (GO:0045824) | 2.61719284 |
| 127 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.59284565 |
| 128 | T cell migration (GO:0072678) | 2.59283206 |
| 129 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.58857978 |
| 130 | detection of molecule of bacterial origin (GO:0032490) | 2.58563402 |
| 131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.56730958 |
| 132 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55610619 |
| 133 | ceramide catabolic process (GO:0046514) | 2.54968812 |
| 134 | kynurenine metabolic process (GO:0070189) | 2.54698781 |
| 135 | pinocytosis (GO:0006907) | 2.53652370 |
| 136 | megakaryocyte development (GO:0035855) | 2.53175973 |
| 137 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.52065213 |
| 138 | cellular response to interferon-gamma (GO:0071346) | 2.51470223 |
| 139 | dendritic cell differentiation (GO:0097028) | 2.50974699 |
| 140 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.50945483 |
| 141 | positive regulation of B cell proliferation (GO:0030890) | 2.48919654 |
| 142 | regulation of interferon-beta production (GO:0032648) | 2.48714986 |
| 143 | macrophage activation (GO:0042116) | 2.48320968 |
| 144 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.48117123 |
| 145 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.47773306 |
| 146 | B cell activation (GO:0042113) | 2.47413358 |
| 147 | regulation of leukocyte degranulation (GO:0043300) | 2.47350702 |
| 148 | positive regulation of interleukin-12 production (GO:0032735) | 2.46954549 |
| 149 | regulation of superoxide anion generation (GO:0032928) | 2.46906763 |
| 150 | myeloid cell activation involved in immune response (GO:0002275) | 2.46725374 |
| 151 | cellular response to interleukin-15 (GO:0071350) | 2.46449496 |
| 152 | regulation of necroptotic process (GO:0060544) | 2.46415657 |
| 153 | T cell selection (GO:0045058) | 2.46378879 |
| 154 | negative regulation of B cell apoptotic process (GO:0002903) | 2.45023631 |
| 155 | positive regulation of lamellipodium assembly (GO:0010592) | 2.44785539 |
| 156 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.43903439 |
| 157 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.43753736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.07429715 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.11645099 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.98069526 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.69511363 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.28559388 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.22941940 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17594418 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.14600454 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.07045149 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93809755 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79693488 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.72289661 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.68252916 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.44506765 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42416696 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38512765 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32140214 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30578507 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.25641774 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24782921 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20862952 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18982267 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.18610127 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.18305853 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14701911 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14529080 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.05842691 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03208010 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03122484 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01940688 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01399309 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99095650 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.98996459 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98865683 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96191535 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95901048 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92310618 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.92291186 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88628190 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87621086 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81364745 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.81057127 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75353153 |
| 44 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.74709798 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72990780 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69258740 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68762971 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61290517 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57688334 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51510217 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.48775147 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48469587 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.47236295 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.44265619 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.43294076 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42424775 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.41808499 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40965049 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39841132 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37285837 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35763767 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35722731 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35297247 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33401730 |
| 65 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.33354819 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.33123167 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.32284775 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31933795 |
| 69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29260549 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28466268 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.28347353 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26638326 |
| 73 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24714797 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23757407 |
| 75 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21139983 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20421933 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20391152 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20125189 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18461441 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17762507 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17138752 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16698681 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16363688 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15948285 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14603964 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11991814 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11440850 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.11192368 |
| 89 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10258920 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.09840555 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08793183 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08068273 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07699173 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06326782 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05296334 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04631323 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.03349322 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02307207 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02055141 |
| 100 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.00880522 |
| 101 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00230119 |
| 102 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00186070 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99215928 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98951733 |
| 105 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.98917004 |
| 106 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98860576 |
| 107 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98497473 |
| 108 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98330562 |
| 109 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98213749 |
| 110 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97074046 |
| 111 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.96316473 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96090419 |
| 113 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95396143 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94855118 |
| 115 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94738103 |
| 116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92929832 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.92688332 |
| 118 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91225764 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90613600 |
| 120 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87704237 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86810807 |
| 122 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86539775 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85531017 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85121648 |
| 125 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84515978 |
| 126 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.83065720 |
| 127 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.81067923 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80664683 |
| 129 | P300_27268052_Chip-Seq_Bcells_Human | 0.80414397 |
| 130 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.80307321 |
| 131 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79949297 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77452076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.96683106 |
| 2 | MP0001800_abnormal_humoral_immune | 3.48844457 |
| 3 | MP0000685_abnormal_immune_system | 3.42786258 |
| 4 | MP0001790_abnormal_immune_system | 3.39313376 |
| 5 | MP0005387_immune_system_phenotype | 3.39313376 |
| 6 | MP0002452_abnormal_antigen_presenting | 2.99705883 |
| 7 | MP0005671_abnormal_response_to | 2.84946867 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.67470079 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.65886695 |
| 10 | MP0002723_abnormal_immune_serum | 2.65771761 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.61688181 |
| 12 | MP0003303_peritoneal_inflammation | 2.60948384 |
| 13 | MP0001819_abnormal_immune_cell | 2.58509895 |
| 14 | MP0009785_altered_susceptibility_to | 2.49467357 |
| 15 | MP0002398_abnormal_bone_marrow | 2.44335711 |
| 16 | MP0002419_abnormal_innate_immunity | 2.39059568 |
| 17 | MP0005025_abnormal_response_to | 2.38694587 |
| 18 | MP0003436_decreased_susceptibility_to | 2.33376245 |
| 19 | MP0000716_abnormal_immune_system | 2.26629774 |
| 20 | MP0001873_stomach_inflammation | 2.20396512 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.17764624 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.15660552 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.06972351 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.02074564 |
| 25 | MP0004510_myositis | 2.01730967 |
| 26 | MP0002722_abnormal_immune_system | 1.95405093 |
| 27 | MP0002429_abnormal_blood_cell | 1.94250119 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.92788760 |
| 29 | MP0002405_respiratory_system_inflammati | 1.89336634 |
| 30 | MP0001853_heart_inflammation | 1.81395079 |
| 31 | MP0009840_abnormal_foam_cell | 1.74659548 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.74511211 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.72924414 |
| 34 | MP0000015_abnormal_ear_pigmentation | 1.72847029 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.72258942 |
| 36 | MP0004947_skin_inflammation | 1.67172698 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.64491222 |
| 38 | MP0000604_amyloidosis | 1.63975980 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.61666120 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.61499496 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.60580764 |
| 42 | MP0002254_reproductive_system_inflammat | 1.53872804 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.52243867 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.50051000 |
| 45 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49797182 |
| 46 | MP0006082_CNS_inflammation | 1.46466044 |
| 47 | MP0003136_yellow_coat_color | 1.46364927 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.45297654 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.45297654 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.43840628 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.43652099 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.41256037 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.40169594 |
| 54 | MP0008469_abnormal_protein_level | 1.37878364 |
| 55 | MP0002006_tumorigenesis | 1.37671408 |
| 56 | MP0004381_abnormal_hair_follicle | 1.35836060 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.34679126 |
| 58 | MP0003693_abnormal_embryo_hatching | 1.31603605 |
| 59 | MP0009278_abnormal_bone_marrow | 1.28866200 |
| 60 | MP0003075_altered_response_to | 1.26812956 |
| 61 | MP0003724_increased_susceptibility_to | 1.24785163 |
| 62 | MP0005310_abnormal_salivary_gland | 1.17902090 |
| 63 | MP0003866_abnormal_defecation | 1.16856691 |
| 64 | MP0005365_abnormal_bile_salt | 1.16379065 |
| 65 | MP0006054_spinal_hemorrhage | 1.16057741 |
| 66 | MP0003077_abnormal_cell_cycle | 1.14871980 |
| 67 | MP0008057_abnormal_DNA_replication | 1.14575580 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.14559142 |
| 69 | MP0000490_abnormal_crypts_of | 1.14377721 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.14197275 |
| 71 | MP0002933_joint_inflammation | 1.11455409 |
| 72 | MP0003646_muscle_fatigue | 1.10527280 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.09505467 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 1.08976583 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.06597743 |
| 76 | MP0010094_abnormal_chromosome_stability | 1.04946948 |
| 77 | MP0005076_abnormal_cell_differentiation | 1.04687765 |
| 78 | MP0009764_decreased_sensitivity_to | 1.04483120 |
| 79 | MP0003195_calcinosis | 1.03946076 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.03920397 |
| 81 | MP0010307_abnormal_tumor_latency | 1.01730093 |
| 82 | MP0000858_altered_metastatic_potential | 1.00619422 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.97910341 |
| 84 | MP0003111_abnormal_nucleus_morphology | 0.96802941 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.96104239 |
| 86 | MP0008004_abnormal_stomach_pH | 0.96011301 |
| 87 | MP0000372_irregular_coat_pigmentation | 0.95969896 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.92794932 |
| 89 | MP0008007_abnormal_cellular_replicative | 0.92749343 |
| 90 | MP0004130_abnormal_muscle_cell | 0.91019290 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.85571269 |
| 92 | MP0000609_abnormal_liver_physiology | 0.84635972 |
| 93 | MP0003448_altered_tumor_morphology | 0.84628361 |
| 94 | MP0003690_abnormal_glial_cell | 0.82586057 |
| 95 | MP0000343_altered_response_to | 0.82389052 |
| 96 | MP0004019_abnormal_vitamin_homeostasis | 0.82375452 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.82114275 |
| 98 | MP0002928_abnormal_bile_duct | 0.80081085 |
| 99 | MP0003045_fibrosis | 0.76691772 |
| 100 | MP0005171_absent_coat_pigmentation | 0.76659819 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.76610743 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.76128188 |
| 103 | MP0002132_abnormal_respiratory_system | 0.75566425 |
| 104 | MP0000598_abnormal_liver_morphology | 0.75487807 |
| 105 | MP0005166_decreased_susceptibility_to | 0.74212118 |
| 106 | MP0009763_increased_sensitivity_to | 0.71214456 |
| 107 | MP0004883_abnormal_blood_vessel | 0.70543046 |
| 108 | MP0005164_abnormal_response_to | 0.70468487 |
| 109 | MP0005075_abnormal_melanosome_morpholog | 0.69500230 |
| 110 | MP0000249_abnormal_blood_vessel | 0.68723353 |
| 111 | MP0004043_abnormal_pH_regulation | 0.67737117 |
| 112 | MP0005390_skeleton_phenotype | 0.67000071 |
| 113 | MP0008058_abnormal_DNA_repair | 0.66891907 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.65585711 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 0.65254960 |
| 116 | MP0005023_abnormal_wound_healing | 0.64629072 |
| 117 | MP0002095_abnormal_skin_pigmentation | 0.64224329 |
| 118 | MP0000313_abnormal_cell_death | 0.63793726 |
| 119 | MP0001663_abnormal_digestive_system | 0.63613408 |
| 120 | MP0001324_abnormal_eye_pigmentation | 0.63442818 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.62166949 |
| 122 | MP0000371_diluted_coat_color | 0.61068524 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.60756181 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.60531237 |
| 125 | MP0001851_eye_inflammation | 0.60039014 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.59877165 |
| 127 | MP0005451_abnormal_body_composition | 0.58105318 |
| 128 | MP0003091_abnormal_cell_migration | 0.58090274 |
| 129 | MP0010329_abnormal_lipoprotein_level | 0.57535751 |
| 130 | MP0000350_abnormal_cell_proliferation | 0.57413033 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56097535 |
| 132 | MP0005621_abnormal_cell_physiology | 0.55893433 |
| 133 | MP0004957_abnormal_blastocyst_morpholog | 0.55820367 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.55301381 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.53594035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.21441063 |
| 2 | IgM deficiency (HP:0002850) | 5.23734167 |
| 3 | Cellulitis (HP:0100658) | 5.02003641 |
| 4 | Recurrent bronchitis (HP:0002837) | 4.91203556 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.87909161 |
| 6 | Chronic otitis media (HP:0000389) | 4.83316121 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.65977316 |
| 8 | Colitis (HP:0002583) | 4.64907078 |
| 9 | Recurrent viral infections (HP:0004429) | 4.61675345 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 4.42315556 |
| 11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.38395197 |
| 12 | Inflammation of the large intestine (HP:0002037) | 4.16900948 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 4.11367600 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.06583368 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.99183883 |
| 16 | Meningitis (HP:0001287) | 3.98285933 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.91618701 |
| 18 | Recurrent sinusitis (HP:0011108) | 3.83316319 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.80384814 |
| 20 | Recurrent skin infections (HP:0001581) | 3.60710435 |
| 21 | Papilloma (HP:0012740) | 3.60555128 |
| 22 | Verrucae (HP:0200043) | 3.60555128 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.53289037 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.53289037 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.53289037 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50374467 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50374467 |
| 28 | Lymphopenia (HP:0001888) | 3.37237614 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31630981 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.31198791 |
| 31 | Chronic sinusitis (HP:0011109) | 3.28640402 |
| 32 | Osteomyelitis (HP:0002754) | 3.27676451 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.25562009 |
| 34 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.25275921 |
| 35 | Mucopolysacchariduria (HP:0008155) | 3.25275921 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.25078773 |
| 37 | Thrombocytosis (HP:0001894) | 3.24323806 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 3.24242075 |
| 39 | Vasculitis (HP:0002633) | 3.24185417 |
| 40 | Myositis (HP:0100614) | 3.17344417 |
| 41 | Emphysema (HP:0002097) | 3.13551979 |
| 42 | Stomatitis (HP:0010280) | 3.10779095 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 3.09432322 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 3.06859113 |
| 45 | Abnormality of B cell number (HP:0010975) | 3.05950776 |
| 46 | B lymphocytopenia (HP:0010976) | 3.05950776 |
| 47 | Nasal polyposis (HP:0100582) | 3.05241373 |
| 48 | Recurrent pneumonia (HP:0006532) | 3.01770242 |
| 49 | Abnormality of T cells (HP:0002843) | 3.00432321 |
| 50 | Thyroiditis (HP:0100646) | 2.94122115 |
| 51 | Decreased circulating renin level (HP:0003351) | 2.91075859 |
| 52 | Recurrent lower respiratory tract infections (HP:0002783) | 2.86504865 |
| 53 | IgA deficiency (HP:0002720) | 2.79747053 |
| 54 | Optic neuritis (HP:0100653) | 2.78393072 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.78393072 |
| 56 | Pustule (HP:0200039) | 2.77876018 |
| 57 | Global brain atrophy (HP:0002283) | 2.76849663 |
| 58 | Bronchitis (HP:0012387) | 2.76459997 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.76117623 |
| 60 | Chronic diarrhea (HP:0002028) | 2.71229531 |
| 61 | Petechiae (HP:0000967) | 2.70128706 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.69094419 |
| 63 | Restrictive lung disease (HP:0002091) | 2.62975660 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.62786985 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.62584026 |
| 66 | Increased serum ferritin (HP:0003281) | 2.56619797 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54474718 |
| 68 | Obstructive lung disease (HP:0006536) | 2.54474718 |
| 69 | Sepsis (HP:0100806) | 2.51688764 |
| 70 | Encephalitis (HP:0002383) | 2.48317032 |
| 71 | IgG deficiency (HP:0004315) | 2.47999893 |
| 72 | Mutism (HP:0002300) | 2.39812042 |
| 73 | Mesangial abnormality (HP:0001966) | 2.39244958 |
| 74 | Periodontitis (HP:0000704) | 2.38548032 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.36716401 |
| 76 | Skin ulcer (HP:0200042) | 2.35541813 |
| 77 | Epistaxis (HP:0000421) | 2.32998515 |
| 78 | Abnormality of the fingertips (HP:0001211) | 2.30777201 |
| 79 | T lymphocytopenia (HP:0005403) | 2.30021421 |
| 80 | Lymphoma (HP:0002665) | 2.28185651 |
| 81 | Increased IgE level (HP:0003212) | 2.26951811 |
| 82 | Congenital sensorineural hearing impairment (HP:0008527) | 2.26686763 |
| 83 | Abnormality of T cell number (HP:0011839) | 2.26558830 |
| 84 | Recurrent otitis media (HP:0000403) | 2.25728199 |
| 85 | Mitral stenosis (HP:0001718) | 2.24901171 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.24812032 |
| 87 | Skin rash (HP:0000988) | 2.24062873 |
| 88 | Viral hepatitis (HP:0006562) | 2.23907840 |
| 89 | Hemoptysis (HP:0002105) | 2.23142584 |
| 90 | Eosinophilia (HP:0001880) | 2.20263243 |
| 91 | Leukopenia (HP:0001882) | 2.17502860 |
| 92 | Hematochezia (HP:0002573) | 2.16545072 |
| 93 | Clumsiness (HP:0002312) | 2.15619309 |
| 94 | Disinhibition (HP:0000734) | 2.15126015 |
| 95 | Abnormal platelet function (HP:0011869) | 2.15032038 |
| 96 | Impaired platelet aggregation (HP:0003540) | 2.15032038 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.13237853 |
| 98 | Pulmonary infiltrates (HP:0002113) | 2.13084906 |
| 99 | Gingival bleeding (HP:0000225) | 2.12347039 |
| 100 | Gingivitis (HP:0000230) | 2.10475874 |
| 101 | Granulocytopenia (HP:0001913) | 2.10057353 |
| 102 | Neutropenia (HP:0001875) | 2.06250604 |
| 103 | Fatigue (HP:0012378) | 2.06221428 |
| 104 | Leukocytosis (HP:0001974) | 2.05892630 |
| 105 | Gastrointestinal infarctions (HP:0005244) | 2.03963459 |
| 106 | Vacuolated lymphocytes (HP:0001922) | 2.03431120 |
| 107 | Purpura (HP:0000979) | 2.02017768 |
| 108 | Arterial thrombosis (HP:0004420) | 2.01447725 |
| 109 | Combined immunodeficiency (HP:0005387) | 2.00705396 |
| 110 | Glomerulonephritis (HP:0000099) | 1.99262531 |
| 111 | Congenital stationary night blindness (HP:0007642) | 1.97600075 |
| 112 | Orchitis (HP:0100796) | 1.94995113 |
| 113 | Increased cerebral lipofuscin (HP:0011813) | 1.94531296 |
| 114 | Abnormality of eosinophils (HP:0001879) | 1.94246786 |
| 115 | Myocardial infarction (HP:0001658) | 1.93869972 |
| 116 | Albinism (HP:0001022) | 1.92519374 |
| 117 | Dysostosis multiplex (HP:0000943) | 1.91311008 |
| 118 | Chest pain (HP:0100749) | 1.89571710 |
| 119 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88748071 |
| 120 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88748071 |
| 121 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88748071 |
| 122 | Urticaria (HP:0001025) | 1.87968481 |
| 123 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87480785 |
| 124 | Loss of speech (HP:0002371) | 1.81395460 |
| 125 | Malnutrition (HP:0004395) | 1.80678314 |
| 126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79655014 |
| 127 | Severe combined immunodeficiency (HP:0004430) | 1.78889010 |
| 128 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75914410 |
| 129 | Absent/shortened dynein arms (HP:0200106) | 1.75914410 |
| 130 | Polyneuropathy (HP:0001271) | 1.74995062 |
| 131 | Progressive visual loss (HP:0000529) | 1.73471942 |
| 132 | Retinal atrophy (HP:0001105) | 1.72736174 |
| 133 | Acrocyanosis (HP:0001063) | 1.72393996 |
| 134 | Abnormality of the pleura (HP:0002103) | 1.72290859 |
| 135 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.71976991 |
| 136 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.71039041 |
| 137 | Keratoconjunctivitis (HP:0001096) | 1.70314161 |
| 138 | Keratoconjunctivitis sicca (HP:0001097) | 1.69576453 |
| 139 | Ovoid vertebral bodies (HP:0003300) | 1.67586758 |
| 140 | Metaphyseal irregularity (HP:0003025) | 1.66071000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.93820250 |
| 2 | ERN1 | 3.12999641 |
| 3 | CSF1R | 2.95856813 |
| 4 | BLK | 2.95324235 |
| 5 | TYK2 | 2.75552623 |
| 6 | ADRBK2 | 2.65087170 |
| 7 | STK10 | 2.63074709 |
| 8 | KIT | 2.62518993 |
| 9 | MAP3K10 | 2.28282266 |
| 10 | MAP3K14 | 2.26307511 |
| 11 | BTK | 2.26228093 |
| 12 | SYK | 2.10282374 |
| 13 | EEF2K | 2.10182196 |
| 14 | MAP3K11 | 2.06546434 |
| 15 | IRAK4 | 2.03415275 |
| 16 | TBK1 | 1.99349996 |
| 17 | JAK3 | 1.98500671 |
| 18 | FLT3 | 1.97910697 |
| 19 | GRK6 | 1.94857988 |
| 20 | TGFBR2 | 1.85825378 |
| 21 | ZAP70 | 1.82582157 |
| 22 | LRRK2 | 1.73932094 |
| 23 | GRK7 | 1.73233737 |
| 24 | JAK1 | 1.73208353 |
| 25 | IKBKB | 1.64782588 |
| 26 | FRK | 1.60541137 |
| 27 | MAP3K13 | 1.58789423 |
| 28 | CAMKK2 | 1.53513083 |
| 29 | TLK1 | 1.51305117 |
| 30 | TEC | 1.45610709 |
| 31 | IKBKE | 1.43959534 |
| 32 | CLK1 | 1.40162974 |
| 33 | RIPK4 | 1.39137510 |
| 34 | CSK | 1.31603951 |
| 35 | CDC42BPA | 1.30255327 |
| 36 | ITK | 1.27116032 |
| 37 | HCK | 1.26773856 |
| 38 | LYN | 1.25900121 |
| 39 | MAPK15 | 1.24968822 |
| 40 | IRAK3 | 1.24440338 |
| 41 | FGFR4 | 1.23577811 |
| 42 | MAP2K3 | 1.22658061 |
| 43 | TRIB3 | 1.22260880 |
| 44 | TNK2 | 1.21176614 |
| 45 | NEK2 | 1.20912161 |
| 46 | TAOK3 | 1.18943105 |
| 47 | MAP3K3 | 1.14763620 |
| 48 | BUB1 | 1.11071922 |
| 49 | CHUK | 1.08246553 |
| 50 | PIM1 | 1.07352666 |
| 51 | CAMK1D | 1.06942166 |
| 52 | MATK | 1.06704298 |
| 53 | EPHB1 | 1.04782200 |
| 54 | PRKD2 | 1.03791479 |
| 55 | DDR2 | 1.03592209 |
| 56 | LCK | 0.99467993 |
| 57 | TAOK1 | 0.99021701 |
| 58 | FGR | 0.97970094 |
| 59 | MARK3 | 0.94515015 |
| 60 | SIK2 | 0.94013789 |
| 61 | BRSK2 | 0.92257913 |
| 62 | FES | 0.90032195 |
| 63 | RPS6KA4 | 0.86246893 |
| 64 | PRPF4B | 0.85691835 |
| 65 | PKN2 | 0.85472090 |
| 66 | PDPK1 | 0.82232350 |
| 67 | IRAK1 | 0.78447070 |
| 68 | STK4 | 0.77672330 |
| 69 | CCNB1 | 0.76966218 |
| 70 | SIK3 | 0.75920114 |
| 71 | CDK4 | 0.75731496 |
| 72 | MAP3K8 | 0.75667456 |
| 73 | CAMKK1 | 0.73661208 |
| 74 | KDR | 0.72159047 |
| 75 | TESK2 | 0.72153559 |
| 76 | ICK | 0.71663640 |
| 77 | PTK6 | 0.68640124 |
| 78 | TAOK2 | 0.68625218 |
| 79 | MAP2K6 | 0.68168058 |
| 80 | DAPK2 | 0.68020360 |
| 81 | JAK2 | 0.67899266 |
| 82 | TXK | 0.65554218 |
| 83 | MAPK11 | 0.64177292 |
| 84 | MAPK4 | 0.61854831 |
| 85 | HIPK2 | 0.61401075 |
| 86 | SIK1 | 0.60759975 |
| 87 | ABL2 | 0.60481079 |
| 88 | FGFR3 | 0.60388104 |
| 89 | MAP2K2 | 0.60351166 |
| 90 | MAP3K1 | 0.59916947 |
| 91 | MARK2 | 0.59906530 |
| 92 | PIM2 | 0.59739632 |
| 93 | ADRBK1 | 0.59433469 |
| 94 | AKT3 | 0.59201677 |
| 95 | WEE1 | 0.58386299 |
| 96 | CDK12 | 0.55780247 |
| 97 | EIF2AK1 | 0.55709506 |
| 98 | EIF2AK3 | 0.55161895 |
| 99 | VRK1 | 0.54626630 |
| 100 | PRKCQ | 0.53602789 |
| 101 | PAK4 | 0.53548475 |
| 102 | NEK9 | 0.51356751 |
| 103 | RPS6KA2 | 0.51084062 |
| 104 | WNK4 | 0.50888671 |
| 105 | RPS6KB2 | 0.50323433 |
| 106 | MELK | 0.50029436 |
| 107 | IRAK2 | 0.48451307 |
| 108 | ABL1 | 0.47620575 |
| 109 | MAPKAPK2 | 0.47152743 |
| 110 | TGFBR1 | 0.45305211 |
| 111 | BRSK1 | 0.44712026 |
| 112 | CDK6 | 0.41945259 |
| 113 | STK24 | 0.41621160 |
| 114 | PDK1 | 0.40323609 |
| 115 | RPS6KA6 | 0.39458988 |
| 116 | INSRR | 0.38260812 |
| 117 | PRKAA2 | 0.38055522 |
| 118 | GRK1 | 0.38024115 |
| 119 | NLK | 0.37957379 |
| 120 | MAPK7 | 0.37867830 |
| 121 | TSSK6 | 0.37760292 |
| 122 | MAPKAPK3 | 0.36848416 |
| 123 | ATR | 0.35873786 |
| 124 | MAP2K1 | 0.35042161 |
| 125 | BMPR1B | 0.35026990 |
| 126 | ACVR1B | 0.34889045 |
| 127 | MAPK12 | 0.34251553 |
| 128 | PIK3CG | 0.32597631 |
| 129 | MST4 | 0.32093164 |
| 130 | TTN | 0.31226145 |
| 131 | DYRK1B | 0.30251334 |
| 132 | PRKCD | 0.29099609 |
| 133 | RPS6KL1 | 0.28140023 |
| 134 | RPS6KC1 | 0.28140023 |
| 135 | STK3 | 0.27877855 |
| 136 | CDK9 | 0.27463679 |
| 137 | BMPR2 | 0.27317435 |
| 138 | EGFR | 0.27022859 |
| 139 | NME2 | 0.26989980 |
| 140 | DYRK3 | 0.26800891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.35293737 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.97057954 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.90751261 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.76391558 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.69785539 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.59800515 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57052004 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.31358117 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.26259021 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21992752 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.20841496 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.14228031 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.91742494 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.87231016 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.77876578 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77092392 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.76856926 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.73508392 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.70770096 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62385225 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58269895 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51907281 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50833128 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50233195 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49103315 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.48461877 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48368158 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.48265665 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.46646069 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45579066 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.43481387 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.42121050 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41482142 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39931086 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38399911 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35029883 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.29681392 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.29260963 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28464307 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.26267426 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25387336 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21079900 |
| 43 | Mismatch repair_Homo sapiens_hsa03430 | 1.19609398 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.16654925 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.14288499 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.09735648 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09448584 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08074294 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.05748947 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.05407194 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.05157347 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04561511 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03406473 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01268987 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99668795 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95308461 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94358321 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.93749866 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92204204 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91978789 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91866532 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.89248501 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88171106 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87865332 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87435606 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86729259 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86310125 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79416297 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79321164 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.75373853 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73803892 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 0.72970662 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72459496 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71140312 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70875324 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70430693 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69629098 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69436453 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66013342 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65740862 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65055839 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61961900 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.60356335 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59510583 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58909833 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58462298 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58262718 |
| 88 | Spliceosome_Homo sapiens_hsa03040 | 0.58262284 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.54301496 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52287789 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50039071 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49905297 |
| 93 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.46676809 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.46621381 |
| 95 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46052612 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45590592 |
| 97 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45581413 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.43379259 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42570517 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.41523309 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41141658 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.40843883 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40255637 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40197665 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39935500 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38562944 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38232975 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35939290 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35507216 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35457849 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34830720 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34762053 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34759395 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34738500 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34378589 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33872241 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33808253 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32851969 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32758767 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30457515 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30400280 |
| 122 | Lysine degradation_Homo sapiens_hsa00310 | 0.30374498 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.29918043 |
| 124 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29709078 |
| 125 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28618993 |
| 126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28333003 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28027615 |
| 128 | RNA transport_Homo sapiens_hsa03013 | 0.27521754 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26876878 |
| 130 | Proteasome_Homo sapiens_hsa03050 | 0.26475174 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.26465833 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26164726 |
| 133 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.25366556 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24078845 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19026394 |
| 136 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.18676390 |
| 137 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18135629 |
| 138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15603892 |
| 139 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14109741 |

